Upregulation of endothelial adhesion molecules in hearts with congestive and ischemic cardiomyopathy: immunohistochemical evaluation of inflammatory endothelial cell activation.

OBJECTIVE In recent years many data emphasized, that inflammatory reactions seem to be involved in the pathogenesis of ischemic (ICM) and congestive (CCM) heart disease. Since, it is well known that endothelial adhesion molecules play a pivotal role in the initiation and maintenance of inflammatory reactions we therefore, evaluated the endothelial expression of a wide variety of different adhesion molecules in hearts suffering from ICM and CCM. METHODS Tissue samples from coronary arteries, and left and right ventricle myocardium originating form heart with ICM and CCM were evaluated. Tissue samples from healthy human donor hearts, which were not transplanted, served as controls. Evaluated adhesion molecule expression: selectin-family ELAM-1, CD62, immunoglobulin-supergene-family PECAM-1, ICAM-1, VCAM-1, integrin-family VLA-1,-2,-3,-4,-5, and -6, complementary-adhesion-molecules CD34, CD44 and the von-Willebrand-factor (vWF). RESULTS While endocardial surfaces and coronary arteries revealed only little differences when comparing tissue samples originating from healthy donor hearts and those suffering from ICM and CCM, significant differences were found within the myocardial microvasculature. Both kinds of diseased hearts showed stronger expressions for CD62, ELAM-1, ICAM-1 and VCAM-1 (only CCM) than controls. More and above, integrin molecules showed differential expressions too. Whereas, VLA-1 showed stronger expressions in diseased hearts, VLA-3,-5, and -6 were expressed much weaker in those hearts. Complementary adhesion molecules (CD34/CD44) did not show significant differences and the vWF was not found in any sample. CONCLUSIONS Inflammatory reactions play a pivotal role in the propagation and maintenance of both these cardiac detoriating diseases.

[1]  Alexander Rw.  Inflammation and Coronary Artery Disease , 1994 .

[2]  S. Albelda,et al.  Differential expression of the cell adhesion molecules ICAM-1, VCAM-1, and E-selectin in normal and posttransplantation myocardium. Cell adhesion molecule expression in human cardiac allografts. , 1994, Circulation.

[3]  B. Strauer,et al.  Methylprednisolone in chronic myocarditis. , 1994, Postgraduate medical journal.

[4]  G. Schmid-Schönbein,et al.  Role of leukocytes in response to acute myocardial ischemia and reflow in dogs. , 1986, The American journal of physiology.

[5]  R. Ross.  The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[6]  M. Yacoub,et al.  Antigenic heterogeneity of vascular endothelium. , 1992, The American journal of pathology.

[7]  Timothy A. Springer,et al.  Adhesion receptors of the immune system , 1990, Nature.

[8]  D. Heney,et al.  Increased circulating adhesion molecule concentrations in patients with the systemic inflammatory response syndrome: A prospective cohort study , 1994, Critical care medicine.

[9]  J. Veinot.  Diagnostic endomyocardial biopsy pathology--general biopsy considerations, and its use for myocarditis and cardiomyopathy: a review. , 2002, The Canadian journal of cardiology.

[10]  R. Alexander,et al.  The dysfunctional endothelium in heart failure. , 1993, Journal of the American College of Cardiology.

[11]  R. Alexander.  Inflammation and coronary artery disease. , 1994, The New England journal of medicine.

[12]  D. Granger,et al.  Role of CD11/CD18 in shear rate-dependent leukocyte-endothelial cell interactions in cat mesenteric venules. , 1991, The Journal of clinical investigation.

[13]  K. Bienvenu,et al.  Leukocyte adhesion in ischemia/reperfusion. , 1993, Blood cells.

[14]  T. Inoue,et al.  Vasodilatory capacity of coronary resistance vessels in dilated cardiomyopathy. , 1994, American heart journal.

[15]  R. Colvin,et al.  In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts. , 1990, Journal of immunology.

[16]  A. Friedl,et al.  Altered expression of titin and contractile proteins in failing human myocardium. , 1994, Journal of molecular and cellular cardiology.

[17]  M. Davies,et al.  Immunohistologic evidence of myocardial disease in apparently healthy relatives of patients with dilated cardiomyopathy. , 2002, Journal of the American College of Cardiology.

[18]  A. Becker,et al.  Chronic congestive heart failure is associated with a phenotypic shift of intramyocardial endothelial cells. , 1995, Circulation.

[19]  H. Schultheiss,et al.  Immunohistochemistry in dilated cardiomyopathy. , 1995, European heart journal.

[20]  A. Haverich,et al.  Cardiac valve endothelial cells: relevance in the long-term function of biologic valve prostheses. , 1998, The Journal of thoracic and cardiovascular surgery.

[21]  D. Mason,et al.  JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. , 1990, Journal of clinical pathology.

[22]  D. Tousoulis,et al.  Increased plasma adhesion molecule levels in patients with heart failure who have ischemic heart disease and dilated cardiomyopathy. , 2001, American heart journal.

[23]  A. Gown,et al.  Various cell types in human atherosclerotic lesions express ICAM-1. Further immunocytochemical and immunochemical studies employing monoclonal antibody 10F3. , 1992, The American journal of pathology.

[24]  H. Schultheiss,et al.  Expression of cell adhesion molecules in dilated cardiomyopathy: evidence for endothelial activation in inflammatory cardiomyopathy. , 1999, Circulation.